Skip to content

A Novel Myocardial Impedance Mapping System for Ablation of Post-infarction Ventricular Arrhytmias in Humans

A Novel Myocardial Impedance Mapping System for Ablation of Post-infarction Ventricular Arrhytmias in Humans

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04000412
Enrollment
25
Registered
2019-06-27
Start date
2019-03-19
Completion date
2022-02-25
Last updated
2019-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infarction, Myocardial, Ventricular Arrythmia

Keywords

electrical impedance, cardiac radiofrequency ablation

Brief summary

Precise identification of the infarct scar is essential for successful catheter ablation of ventricular arrhythmias in patients with chronic myocardial infarction. Voltage mapping of endocardial electrograms is currently used to delineate the necrotic scar but this is influenced by the direction of the activation wave front and is not sensitive enough to differentiate distinct degrees of transmural injury in the scar. Mapping of local myocardial electrical impedance may overcome these limitations.

Detailed description

Clinical series: Patients with chronic infarction undergoing catheter ablation of ventricular arrhythmias will be submitted to mapping of both voltage and tissue impedance. Likewise, the accuracy of the two maps identifying the extent and transmurality of the infarction will be assesssed by gadolinium imaging. The impedance system is already constructed and certified for clinical research use.

Interventions

DEVICECardioZ multifrequency impedance recording system

Patients will be submitted to mapping of both voltage and tissue impedance. The accuracy of the two maps identifying the extent and transmurality of the infarction will be assesssed by gadolinium imaging.

Sponsors

Universitat Politècnica de Catalunya
CollaboratorOTHER
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* More than 18 yearts * Chronic myocardial infarction * Undergoing ventricular ablation of ventricular arrhythmias

Exclusion criteria

* patients with device not suitable for cardiac magnetic ressonance (CMR) * pregnacy

Design outcomes

Primary

MeasureTime frameDescription
Comparative detection of infarct scar by voltage mapping3 hoursVoltage will be measured at different sites of the infarct scar and healthy tissue.
Comparative detection of infarct scar by impedance mapping3 hoursmyocardial local impedance will be measured at different sites of the infarct scar and healthy tissue.
Comparative detection of infarct scar by gadolinium enhanced MR imaging30 minutesIntensity of gadolinium will be measured at different sites of the infarct scar and healthy tissue.

Countries

Spain

Contacts

Primary ContactJuan Cinca Cuscullola, Professor
jcinca@santpau.cat+34935537058
Backup ContactLaia Angli
langli@santpau.cat+34935537058

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026